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ABSTRACT: Tunable biomaterials that mimic selected features of the extracellular matrix (ECM), such 
as its stiffness, protein composition, and dimensionality, are increasingly popular for studying how cells 
sense and respond to ECM cues. In the field, there exists a significant trade-off for how complex and how 
well these biomaterials represent the in vivo microenvironment, versus how easy they are to make and 
how adaptable they are to automated fabrication techniques. To address this need to integrate more 
complex biomaterials design with high-throughput screening approaches, we present several methods to 
fabricate synthetic biomaterials in 96-well plates and demonstrate that they can be adapted to semi-
automated liquid handling robotics. These platforms include 1) glass bottom plates with covalently 
attached ECM proteins, and 2) hydrogels with tunable stiffness and protein composition with either cells 
seeded on the surface, or 3) laden within the three-dimensional hydrogel matrix. This study includes 
proof-of-concept results demonstrating control over breast cancer cell line phenotypes via these ECM 
cues in a semi-automated fashion. We foresee the use of these methods as a mechanism to bridge the 
gap between high-throughput cell-matrix screening and engineered ECM-mimicking biomaterials.  
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 INTRODUCTION  
Synthetic biomaterials are valuable platforms for studying cell behavior in vitro because they 
capture some features of real tissue microenvironments. These factors are missed using standard tissue 
culture polystyrene (TCPS) and are not easily modified using in vivo models. Many have used engineered 
biomaterials to better understand biological processes such as organoid development,1 stem cell 
differentiation,2-3 tumor progression,4-5 and drug response.6-7 Bioengineers in the field have developed 
many different classes of biomaterial systems in which to study cell-extracellular matrix (ECM) 
interactions. These can be protein or peptide-based systems, or made from synthetic polymer 
precursors.8 We focus here on this latter class of materials because they are engineered from the ground-
up, and provide a plethora of tunable characteristics to direct cell function. These biomaterials have been 
developed to either allow for cell culture on their surfaces (Two-dimensional (2D) hydrogels), or to allow 
for encapsulation within the material (Three-dimensional (3D) hydrogels). 3D hydrogel models have been 
used to independently tune biophysical and biochemical cues to determine their impact on intestinal stem 
cell organoid growth,1 cancer cell invasion,9 and drug response.10 Moreover, the dynamics of 
microenvironments have been captured in some 3D models by using photoinitiated polymerization to 
change the hydrogel modulus and ligand density11 and by creating patterns within a hydrogel to control 
the spatial arrangement of biochemical cues within the matrix to direct cell phenotype.12 Lastly, more 
complex material designs that include microfluidics have been used to capture the bone marrow,13 liver,14 
and heterogeneous tumor microenvironments,15-16 or to study the response of lung inflammation17 and 
glioblastoma18 to drugs. While these systems capture fluid flow and spatial gradients, they are generally 
labor-intensive18 and low-throughput,17 which makes expansion to large-scale studies a significant 
challenge.  
One area of interest is using biomaterials to make preclinical and clinical predictions of diseases. 
For example, our group demonstrated that breast cancer cell speed, displacement, and adhesivity were 
dependent on the ECM protein composition coupled to glass, and these phenotypes could be used to 
predict tissue-specific breast cancer metastasis.19 We and others have demonstrated drug that response 
is affected by both stiffness and ECM protein composition on 2D hydrogels.6-7, 20 We have also shown that 
tumor spheroids encapsulated into 3D hydrogels are drug resistant compared to TCPS.10 Additionally, 
 biomaterials can be used to predict stage-specific phenotypes in disease. For example, early stage 
melanoma cell drug response was shown to be insensitive to the dimensionality of the platform, but 
metastatic melanoma cells were resistant in 3D environments.21 These studies demonstrate controlled in 
vitro ECMs are useful tools for preclinical studies.  
The need for engineered biomaterials in the drug development pipeline is clear, since only 8% of 
filed Investigational New Drug applications will be approved by the Food and Drug Administration.22 This 
is due in part to false positives missed early in the drug development pipeline. Therefore, there is a critical 
need to scale up these types of biomaterials in order for them to be feasible for high-throughput 
screening. To achieve a paradigm shift in high-throughput screening with biomaterials, they must be 
formatted to use existing equipment and technology, such as liquid handling robotics and plate readers.23  
To address this need, we integrated three biomaterials our lab has developed into 96-well plates and 
used semi-automated liquid handling robotics to fabricate these platforms (Figure 1). In this study, we 
give a detailed overview of their development, use, and how they can be made amenable to semi-
automated technologies. They range from the simplest, chemically modified glass surfaces, to a 
significantly more complex tunable 3D hydrogel cell culture system. We propose that each of these 
platforms are incredibly useful for in vitro studies of cell-ECM interactions, and the level of complexity 
chosen by an individual lab should be guided by the biological question at hand. 
  
 MATERIALS AND METHODS 
Cell culture. All cell culture supplies were purchased from Thermo Fisher Scientific (Waltham, 
MA). MDA-MB-231 and Hs578T breast cancer cell lines were grown in Dulbecco’s Modified Eagle 
Medium (DMEM), supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin 
(pen/strep) at 37C and 5% CO2. The MDA-MB-231 cell line was provided by Dr. Sallie Smith Schneider 
at the Pioneer Valley Life Sciences Institute, and Hs578T cells were provided by Dr. Mario Niepel at 
Harvard Medical School.  
Custom 96-well plate fabrication. We used bottomless polystyrene 96-well plates (Greiner Bio-
One, Kremsmünster, Austria) as the base of the custom well plate. We manually cut a rectangular piece 
of ARcare 90106 (Adhesives Research, Glen Rock, PA)24 medical-grade, double-sided adhesive to fit the 
well plate bottom, and it was attached to the plate by hand ensuring that there were no air bubbles 
present. Holes were cut in the adhesive from a custom template designed in Adobe Illustrator CC 2014 
(Adobe Systems, San Jose, CA) with a laser cutter (Epilog Mini 18 Laser, Golden, CO). We purchased 
glass pieces cut to size (110 mm x 75 mm, S.I. Howard Glass, Worcester, MA) with the same thickness 
as a number 1.5 coverslip (0.17 mm) to optimize microscopy applications. We adhered the glass to the 
plate by removing the remaining backing to the adhesive and pressing the glass firmly to ensure a tight 
seal around each well. The glass was attached to the plate before or after chemical modification, 
depending on the biomaterial platform (Figure S1).  
Basic liquid handling robotics operation. We have a Biomek NXP Liquid Handling Automation 
Workstation (Biomek, Beckman Coulter, Brea, CA) configured with 250 L syringe pumps. This 
instrument is enclosed in a 1.0 m x 0.9 m Biomek NXP Negative Pressure HEPA Enclosure (Beckman 
Coulter) to enable sterile cell culture. With the instrument powered on, we ran the Biomek software 
(version 4.1) on the computer connected to the Biomek to control the instrument. Each day of an 
experiment, we ran the “Home All Axes” method until we observed that no air bubbles were present in the 
syringes. Individual methods were created for each platform and experiment with the Biomek software. 
We primarily used the “Aspirate” and “Dispense” functions within the software to perform protein solution 
dilutions and to pipette the 2D and 3D hydrogel pre-polymer solutions into our 96-well plate platforms.  
 ECM protein well plates. ECM proteins were attached to the glass surface in a 96-well plate 
format by modifying a procedure described previously.19 For each plate, one 110 mm x 75 mm piece of 
glass was UV/ozone treated at 1 atmosphere (UV/Ozone ProCleaner, 180 micrograms/m3 ozone level in 
chamber, 4.6 mW/cm2 peak UV intensity, 10.15 W UV lamp power requirement, BioForce Nanosciences, 
Salt Lake City, UT) for 10 minutes to hydroxylate the surface. The glass was placed in an inverted well 
Figure 1. Schematic of three high-throughput, 96-well biomaterial platforms for studying cell behavior in vitro. a. To make 
protein-modified glass-bottom plates, we chemically modified a well plate-sized piece of glass. This glass was attached to a 
bottomless 96-well plate and ECM proteins (purple and blue) were attached in solution with three hours of surface contact followed 
by a PEG blocking step for two hours before cell (green) seeding. b. 2D PEG-PC hydrogels were covalently attached to fully 
assembled glass bottom 96-well plates functionalized with a methacrylate silane. The hydrogels were functionalized with full length 
proteins via sulfo-SANPAH before cell seeding. c. 3D PEG-MAL hydrogels were covalently attached to fully assembled glass 
bottom 96-well plates functionalized with MPT. The PEG-MAL (4-arm, purple) pre-polymer solution containing cell-adhesion 
(black/blue) and cell-degradable (black/orange) peptides was mixed with single cells and the PEG-dithiol crosslinker (gray), and 
allowed to polymerize on the silane-functionalized glass surface.  
 
 plate lid supported by small acrylic posts to allow for air flow on both sides of the glass. (3-
aminopropyl)triethoxysilane (APTES, Sigma-Aldrich, St. Louis, MO) was deposited into inverted 
polypropylene lids spaced evenly around the glass. Another well plate lid was placed on top and this 
container was sealed with autoclave tape and wrapped in aluminum foil. This was placed in a 90C oven 
to functionalize the glass with APTES by vapor deposition overnight as previously described.25 The glass 
was rinsed four times sequentially in toluene (Thermo), 95% ethanol (Pharmco-AAPER, Brookfield, CT), 
and water. The glass was dried at 90C for one hour and then functionalized with 10 g/L N,N-
disuccinimidyl carbonate (DSC, Sigma-Aldrich) and 5 v% N,N-Diisopropylethylamine (DIEA, Sigma-
Aldrich) in acetone (Thermo) for two hours. The glass was rinsed three times in acetone, air-dried, and 
used immediately or stored in a desiccator overnight. The surface of each well was coated with a 40 L 
protein solution containing 0, 0.13, 0.25, 0.5, 1, or 2 g/cm2 collagen I (rat tail, Thermo) with or without the 
addition of a constant 0.5 g/cm2 fibronectin (human, Millipore, Billerica, MA) background diluted in pH 
7.4 phosphate buffered saline (PBS) by manual pipetting or with liquid handling robotics (Biomek). The 
plates were rinsed three times with PBS and the remaining surface area was blocked with 10 g/cm2 
MA(PEG)24 (Thermo) for two hours to prevent non-specific protein adsorption. The wells were rinsed 
three times, and UV sterilized for one hour before cell seeding. MDA-MB-231 or Hs578T cells were 
seeded in serum free cell culture medium at 3,400 cells/cm2 and were imaged with an Axio Observer Z1 
(Carl Zeiss AG, Oberkochen, Germany) one day post-seeding, N  85 cells were analyzed per condition.  
X-ray photoelectron spectroscopy (XPS) analysis. Glass coverslips (15 mm diameter, number 
1.5, Thermo) were treated with UV/ozone, APTES, DSC, and 2 g/cm2 of the cell-adhesion peptide 
GSPCRGDG (RGD, Genscript, Piscataway, NJ) as described above. Coverslips were used instead of 
large pieces of glass to fit into the instrument for analysis. Coverslips representative of each treatment 
step were analyzed by XPS (Physical Electronics Quantum 2000 Scanning ESCA microprobe, Physical 
Electronics, Inc., Chanhassen, MN). Spectra were obtained with a 200 m spot size and monochromatic 
Al K radiation (1,486.68 eV). The x-ray source was operated at 45.9 W with the analyzer’s constant pass 
energy at 187.85 eV. The take off angle was 45 from the sample surface and N = 2 locations per sample. 
 2D hydrogel platform. 2D poly(ethylene glycol)-phosphorylcholine (PEG-PC) hydrogels were 
synthesized using modifications to a method described previously.6 Briefly, fully assembled glass bottom 
96-well plates were UV/ozone treated (BioForce Nanosciences) for 10 minutes. A 2 v% solution of 3-
(trimethoxysilyl)propyl methacrylate (MPS, Sigma-Aldrich) in 95% ethanol (adjusted to pH 5.0 with glacial 
acetic acid) was used to silane-functionalize the wells for five minutes. The wells were rinsed three times 
with 100% ethanol and dried in an oven. A 17 wt% solution of 2-methacryloyloxyethyl phosphorylcholine 
(PC, Sigma-Aldrich) in pH 7.4 PBS was mixed with 1, 3, 6, and 10 wt% poly(ethylene glycol) 
dimethacrylate (PEGDMA, Mn 750, Sigma-Aldrich). These PEG-PC solutions were clarified by filtering 
through a 0.2 m syringe filter (Thermo). Hydrogel polymerization was initiated by lithium phenyl(2,4,6-
trimethylbenzoyl)phosphinate (LAP, TCI America, Portland, OR).26 LAP at 200 mM dissolved in 70% 
ethanol was added to the pre-polymer solutions to a final concentration of 2 mM to polymerize the 
hydrogels.26 PEG-PC hydrogels were formed either manually using a multi-channel pipette or with liquid 
handling robotics (Biomek) by adding 40 L of the pre-polymer solution to the wells and placing the plates 
under UV light (365 nm, UV Panel HP, American DJ, Los Angeles, CA) to induce hydrogel polymerization 
for at least 20 minutes. Post-polymerization, 100 L PBS was added to each well to allow the hydrogels 
to swell overnight. Fully swollen hydrogels ranged from 500 to1000 μm thick depending on the ratio of 
PEG to PC. 
 The swollen hydrogels were functionalized with protein by reacting with 0.6 mg/mL 
sulfosuccinimidyl 6-(4'-azido-2'-nitrophenylamino)hexanoate (sulfo-SANPAH, ProteoChem, Denver, CO) 
dissolved in (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES) buffer (pH 8.5) under 365 nm 
UV light for at least 20 minutes. The hydrogels were rinsed three times with HEPES buffer. Protein 
solutions in pH 3.8 PBS were added to the wells for a final protein concentration of 5 g/cm2 containing 
either collagen I alone (Thermo) or a “collagen-rich” solution containing 65% collagen I (Thermo), 33% 
collagen III (recombinant human, FibroGen, San Francisco, CA), and 2% fibronectin (Millipore).6 The 
plates were stored at 4C overnight and rinsed three times with pH 3.8 PBS, followed by three rinses with 
pH 7.4 PBS, UV sterilized for one hour, and then rinsed with cell culture medium prior to cell seeding. 
MDA-MB-231 cells were seeded at 34,000 cells/cm2 and Hs578T cells were seeded at 17,000 cells/cm2.  
 3D hydrogel platform. Glass bottom 96-well plates were UV/ozone treated (BioForce 
Nanosciences) for 10 minutes and functionalized with 2 v% solution of (3-
mercaptopropyl)trimethoxysilane (MPT, Thermo) in 95% ethanol (adjusted to pH 5.0 with glacial acetic 
acid) for five minutes. The wells were rinsed three times with 100% ethanol and dried in an oven. For 
mechanical testing and hydrogel survival studies no cells were encapsulated into the hydrogels. A 4-arm 
PEG-maleimide (PEG-MAL, 20 kDa 4-arm PEG-MAL, Jenkem Technology, Plano, TX) was dissolved at 
5, 10, or 20 wt% in serum free DMEM and crosslinked at a 1:1 ratio with linear PEG-dithiol (PDT, 1 kDa, 
Sigma-Aldrich) dissolved in 2 mM triethanolamine (pH 7.4) as a catalyst.27 Final hydrogel volume was 10 
L, which covers the surface of the well once swollen. After waiting five minutes to ensure hydrogels were 
completely polymerized, the hydrogels were swollen overnight by adding 100 L/well PBS. Fully swollen 
hydrogels were approximately 500 μm thick. Cells were encapsulated into 3D PEG-MAL hydrogels as 
described previously10 with minor modifications. Briefly, a 10 wt% solution of PEG-MAL containing 2 mM 
of cell-adhesion peptide RGD (GRGDSPCG, Genscript), GFOGER (CGP(GPP)5GFOGER(GPP)5, 
Genscript), DGEA (GCGDGEA, see the Supplemental Information), or no cell-adhesion peptide was 
combined with either MDA-MB-231 or Hs578T cells at 500,000 cells/mL. This solution was crosslinked at 
a 1:1 with linear PDT (1 kDa, Sigma-Aldrich) or a 1:1 molar combination of the linear PDT and cell-
degradable crosslinker, Pan-matrix metalloproteinase (Pan-MMP, GCRDGPQGIWGQDRCG, Genscript) 
in sterile 2 mM triethanolamine. The hydrogels were synthesized by pipetting 1 L of the PDT or PDT and 
Pan-MMP solution onto the well surface manually or with the liquid handling robotics followed by pipetting 
9 L of the cell-containing PEG-MAL solution manually near the well surface or with the liquid handling 
robotics at 5 mm above the well surface to prevent polymerization of the hydrogels at the pipette tips. 
Collagen I ELISA. Plates were prepared as described above with solutions containing 0-2 
g/cm2 collagen I alone or with an additional 0.5 g/cm2 fibronectin background with manual pipetting. 
The plates were blocked with non-specific protein by incubating overnight at 4C with AbDil (2 wt% bovine 
serum albumin (Thermo) in tris-buffered saline (TBS) with 0.1% Triton x-100 (Sigma-Aldrich), TBS-T). 
The AbDil was removed and a 1:200 dilution of a collagen I antibody (ab6308, Abcam, Cambridge, MA) in 
AbDil was added to each well and incubated for one hour while rotating the plate. The primary antibody 
was removed and the wells were rinsed three times with washing buffer (0.5% Tween 20 (Sigma-Aldrich) 
 in PBS). The secondary anti-mouse HRP antibody (PI31430, Thermo) was added at a 1:20,000 dilution in 
AbDil for one hour while rotating the aluminum foil-wrapped plate. The antibody was removed and the 
wells were rinsed three times with washing buffer and then 50 L of Pierce 1-Step Ultra TMB-ELISA 
Substrate Solution (PI34028, Thermo) was added to each well. The plate was incubated in the dark for 15 
minutes. The reaction was quenched by adding 50 L/well 2 M sulfuric acid. The absorbance was read at 
450 nm (BioTek ELx800 microplate reader, BioTek, Winooski, VT). For the plotted data for the collagen I 
only ELISA, N = 2 independent experiments and n = 3 technical replicates. For the collagen I with 
fibronectin background, n = 3 technical replicates. The data are plotted as the mean  standard error of 
the mean (SEM) in both cases.  
Hydrogel mechanical characterization. A custom-built instrument described previously28 was 
used to measure the effective Young’s modulus of the 2D PEG-PC and 3D PEG-MAL hydrogels made in 
96-well plates (manual or semi-automated pipetting) and on coverslips (manual pipetting). Here, 
indentation testing was performed on 40 L 2D hydrogels and 10 L 3D hydrogels. In brief, a flat punch 
cylindrical probe (custom made using a High-Speed M2 Tool Steel Hardened Undersized Rod from 
McMaster Carr, Elmhurst, IL, diameter 3.1-5.2 mm) was brought into contact with the surface of the 
hydrogel at a rate of 10 m/s to a maximum displacement of 100 m. The sample height (h) to the contact 
radius (a) was kept between 0.5<a/h<2 and material compliance was analyzed using a correction ratio 
between the contact radius and the sample height to account for the dimensional confinement, as 
previously described.29 This modified Hertzian model was used to analyze the first 10% of the linear 
portion of the force-indentation curve.29 For mechanical characterization, N  4 hydrogels per condition. 
Hydrogel survival and silane stability curves. For the hydrogel survival curves, 2D PEG-PC 
and 3D PEG-MAL hydrogels were synthesized as described above in 96-well plates (manual or semi-
automated pipetting) or on coverslips (manual pipetting) and swollen in PBS. The PBS was 
replenished/changed two to three times per week and hydrogel covalent attachment was verified with 
plate inversion and visual inspection. For the hydrogel survival curves, N  6 hydrogels per condition. For 
the silane chemistry stability, 15 mm diameter glass coverslips were prepared with the MPT chemistry 
described above and stored in a 24-well plate on the bench or in a desiccator. At each time point, three 
new 10 wt% PEG-MAL hydrogels were synthesized manually with 1:1 crosslinking with linear PDT. PBS 
 was added to each well and hydrogel adherence was determined by visual inspection after five minutes. 
Immunofluorescence staining. Breast cancer cells seeded on TCPS or 2D PEG-PC hydrogels 
(10 wt% PEGDMA) were fixed and stained one day post-seeding. Cells were rinsed three times with 
warm PBS, fixed with 10% formalin (Thermo) at 37C for 20 minutes. Cells were rinsed again three times 
with PBS, permeabilized with TBS + 0.5% Triton x-100 for 10 minutes, rinsed three times with PBS and 
blocked in AbDil for 20 minutes. A 1:300 dilution of a monoclonal mouse anti-vinculin antibody (V9264, 
Sigma-Aldrich) in AbDil was added to the wells for one hour while the plate was gently rotated, removed, 
and the cells were rinsed three times with TBS-T. A 1:500 dilution of Alexa Fluor anti-mouse 555 
(Thermo) was added for 45 minutes while the aluminum foil-wrapped plate was gently rotated. The 
hydrogels were rinsed three times with TBS-T. To stain for F-actin, 1:40 dilution of Alexa Fluor 647 
phalloidin (Thermo) in PBS was added to the wells for 20 minutes while gently rotating the aluminum foil-
wrapped plate. The cells were rinsed three times with PBS. The nuclei were stained with a 1:10,000 
dilution of DAPI (Thermo) in PBS for five minutes. The cells were rinsed three times with PBS. Cells were 
imaged using a Zeiss Spinning Disc Cell Observer SD (Zeiss). The images shown are representative from 
a set of N = 2 independent experiments. 
LIVE/DEAD cell viability staining. At one and four days after encapsulation in 3D PEG-MAL 
hydrogels, cells were evaluated for viability by LIVE/DEAD staining (L3224, Thermo) in accordance with 
the manufacturer’s instructions. Cells in the hydrogels were imaged using a Zeiss Spinning Disc Cell 
Observer SD (Zeiss). The results were quantified by manually counting the cells in the images, N  6.  
Image processing. Cell morphology was evaluated by manual tracing in ImageJ (National 
Institutes of Health, Bethesda, MD). For cells on ECM well-plates, N  85. The LIVE/DEAD image stacks 
of the cells encapsulated in the 3D hydrogels were converted to 2D images in Imaris x64 7.7.2 (Bitplane, 
Belfast, United Kingdom) using the Easy 3D display mode. The results were quantified by manually 
counting the cells in the images, N  6. 
Statistical analysis. Statistical analysis was performed with GraphPad Prism v7.0c (GraphPad 
Software, Inc., LaJolla, CA). Statistical significance was evaluated using a one-way analysis of variance 
(ANOVA) followed by a Tukey’s post-test for pairwise comparisons. For the analysis, p-values <0.05 are 




Three distinct biomaterial platforms adapted to 96-well plates and liquid handling robotics. 
We previously developed a biomaterial system with ECM proteins covalently attached to glass, providing 
control over the integrin-binding of the cells by changing the protein composition on the surface.19 This 
chemistry was initially developed for single coverslips, and this method was incompatible with semi-
automated applications. To optimize this chemistry for multi-well plates, we applied this same silane 
chemistry on a well plate-sized piece of glass (Figure 1a). We used UV/ozone treatment to promote 
surface hydroxylation followed by overnight chemical vapor deposition of APTES. We functionalized the 
surface with DSC to provide the amine-reactive succinimidyl ester and then attached the glass to a 
bottomless 96-well plate with a medical grade adhesive (Figure S1a-b). Then, the desired single protein 
or protein combination was covalently attached within each well using semi-automated liquid handling 
robotics. The remaining surface area was blocked with non-specific PEG to ensure that the cells would 
only bind to the intended proteins on the surface. Then, cells were seeded into the wells for experiments.  
2D PEG-PC hydrogels were synthesized in 96-well plates with an efficient photoinitiator (Figure 
1b). We improved this platform from our initial adaptation in a 96-well plate6 by using semi-automated 
liquid handling robotics to pipette the pre-polymer solution of the 2D PEG-PC hydrogels, and by initiating 
the polymerization with UV light in a 96-well plate. Fully assembled glass bottom 96-well plates were 
UV/ozone treated and then functionalized with a solution of MPS. This silane functionalization on the 
glass surface reacted with the methacrylates in the PEGDMA, which covalently attached the 2D 
hydrogels to the glass during polymerization. We tuned the hydrogel stiffness by varying the mesh size of 
the hydrogel network, and these hydrogels were functionalized with proteins via the amine-reactive sulfo-
SANPAH before seeding cells. 
We also adapted 3D PEG-MAL hydrogels10 to a 96-well plate format (Figure 1c). Briefly, fully 
assembled glass bottom 96-well plates were UV/ozone treated and functionalized with a solution of MPT. 
The MPT presents a thiol group, which reacts with the maleimide to covalently attach the 3D hydrogel to 
the plate. This 3D platform consisting solely of PEG and peptides is the quickest platform to fabricate: the 
plate functionalization, pre-polymer solution, and cell seeding can all be completed within a few hours.  
Custom-built 96-well plates with covalently bound, full-length ECM proteins and protein 
 combinations. To create a 96-well plate system with precisely tailored integrin-binding ECM proteins, we 
modified commercially available glass with aminated silane (Figure 1a).19 We performed XPS to ensure 
that the silane chemistry resulted in the appropriate functional groups after each reaction step (Figure 2a). 
We covalently attached the cell-binding peptide RGD (GRGDSPCG) to the surface of the glass in lieu of a 
full-length protein due to the limitations of the XPS resolution being able to detect elements extending 
only a short distance from the substrate surface. Our XPS results indicated that we did not start with 
perfectly clean glass, demonstrated by the detection of carbon on the surface. Following APTES vapor 
deposition, we expected and observed an increase in carbon relative to silicon, a 3:1 ratio of carbon to 
nitrogen, and a 1:1 ratio of silicon to nitrogen. We observed an increase in carbon relative to silicon after 
the DSC reaction, with relatively unchanged ratios of oxygen and nitrogen to silicon. This indicates a sub-
stoichiometric reaction of the DSC to the surface, which could be due to imperfectly clean glass at the 
start, or reaction of the succinimydil carbonate with adjacent free nitrogens. Finally, with the addition of 
we observed an expected increase of nitrogen relative to silicon, approximately consistent with the 
efficacy of the DSC reaction in the third step (Figure 2b).  
To demonstrate the ability to tune ECM protein concentration and combinations, we coupled 
solutions containing 0-2 g/cm2 of full-length collagen I to the amine-reactive glass surfaces. The surface 
concentrations were the expected maximum theoretical surface concentrations based on the solution 
concentrations. We quantified the protein coupling with a modified ELISA and observed a statistically 
significant increase in collagen I over the range of concentrations that we tested (Figure 2c). Real tissues 
are comprised of multiple proteins,30-31 therefore, we performed the same collagen I range quantification 
against a background of a constant concentration of fibronectin in the mixture. Again, we detected a 
statistically significant change in collagen I concentration across this range while in this ECM protein 
mixture (Figure 2d).  
 We then used this tunable glass bottom plate system to demonstrate changes in cell phenotype 
according to changes in collagen I surface concentrations. We quantified cell area (Figure 2e) and 
Figure 2. APTES-DSC chemistry allows for ECM protein coupling to glass bottom 96-well plates to control cell 
binding. a. Schematic of the chemical functionalization steps to create the ECM proteins attached to glass platform. b. 
XPS analysis of glass coverslips at each modification step. The percentage of carbon (C), oxygen (O), silicon (Si), and 
nitrogen (N) on the surface after each chemical step (ordered left to right). N = 2 locations per sample were used for 
quantification. Data are mean  SEM. c. Modified ELISA to quantify the presence of full-length collagen I concentration on 
the well surfaces, N = 6 wells per condition. Data are mean  SEM. d. Modified ELISA to quantify the presence of 
changing collagen I surface concentration with a constant 0.5 g/cm2 fibronectin background. N = 3 wells per condition. 
Data are mean  SEM. e-f. Quantification of MDA-MB-231 and Hs578T cell area (e) and cell circularity (f) as a function of 
collagen I surface concentrations. Individual data points are shown and the red line indicates the mean value at each 
condition, N  85 cells per condition. The collagen I surface concentrations on the x-axes in c-f were the expected 
maximum theoretical surface concentrations based on the solution concentrations that were applied to the surface. 
Statistical significance where p<0.05 is denoted with *, ≤0.01 with **, ≤0.001 with ***, and ≤0.0001 with ****. In Figure 2c-d 
statistical significance with p ≤ 0.01 are not displayed on the graph for simplicity. 
 circularity (Figure 2f) in two breast cancer cell lines: MDA-MB-231 and Hs578T. With increasing collagen I 
concentration, cell area increased in the MDA-MB-231 cells, while there was no statistically significant 
change in Hs578T cell area (Figure 2e). MDA-MB-231 circularity did not change as a function of collagen 
I concentration, but there was a clear decrease in the circularity of the Hs578T cell population with 
increasing collagen I concentration (Figure 2f), demonstrating that this control of ECM protein has a 
measurable effect on typical cell behaviors.   
LAP is an efficient photoinitiator to synthesize 2D PEG-PC hydrogels in a 96-well plate 
format. In addition to protein composition,30-31 every tissue has a specific stiffness range32-33 that can be 
mimicked using hydrogels. We had developed a 2D PEG-PC hydrogel that is polymerized with Irgacure 
2959 (Irgacure),34 a commonly used photoinitiator in hydrogel synthesis.35-37 However, this initiator could 
not be used in a black-walled 96-well plate due to light intensity loss. To overcome this, we used LAP,26 
which forms free radicals more efficiently at 365 nm light than Irgacure.26 We made 1, 3, 6, and 10 wt% 
PEGDMA hydrogels with a constant 17 wt% PC. In the multi-well plates, varying the crosslinker 
(PEGDMA) in the hydrogels allowed for control of the effective Young’s modulus (Figure 3a). Of note, the 
modulus measured for hydrogels created in the 96-well plates was detectably lower than the modulus of 
the same condition made on glass coverslips (Figure S3a). Additionally, the bulk stiffness reported for 
PEG-PC hydrogels synthesized with LAP initiation was softer than what was previously reported for the 
hydrogels that were synthesized using Irgacure for initiation.34 This is likely due to weaker light 
transmittance in black-walled plates.35, 37 
 We also tested the stability of the covalent attachment of these hydrogels to the glass bottom 
surfaces (Figure 3b). This attachment was similar comparing hydrogels attached to the glass-bottom 
Figure 3. 2D PEG-PC hydrogels can be synthesized in a 96-well plate with an efficient photoinitiator. a. 
Indentation testing of 2D PEG-PC hydrogels made at 1, 3, 6, and 10 wt% PEGDMA with a constant 17 v% solution of 
PC shows an increasing effective Young’s modulus with increasing PEGDMA weight percent, N = 10 hydrogels per 
condition. b. Percentage of the hydrogels at each condition that remain covalently attached to the MPS functionalized 
glass bottom 96-well plate throughout 30 days, N  6 hydrogels per condition. c. Immunofluorescence images of 
MDA-MB-231 and Hs578T cell lines on TCPS or PEG-PC hydrogels (10 wt% PEGDMA) coated with an expected 
maximum theoretical surface concentration of either 5 g/cm2 collagen I or 5 g/cm2 comprised of 65% collagen I, 
33% collagen III, and 2% fibronectin. Cells were stained for vinculin (green), F-actin (red), and DNA in the nuclei 
(blue). Scale bar = 100 m. Images are representative of N = 2 biological replicates. Statistical significance where p 
≤0.0001 is denoted with ****. 
 multi-well plates and individual coverslips (Figure S3b), suggesting that the efficacy of the silane 
treatment is similar between the two different glass formats.  
To evaluate our ability to control protein attachment to these hydrogel surfaces, and to 
demonstrate a proof-of-concept study using this system to study cell behavior, MDA-MB-231 and Hs578T 
breast cancer cell lines were seeded on a 10 wt% hydrogel condition coupled with an expected maximum 
theoretical surface concentration of 5 g/cm2 collagen I alone or a “collagen-rich” mixture (65% collagen I, 
33% collagen III, & 2% fibronectin).6 After 24 hours, we fixed and stained the cells (Figure 3c). Both cell 
lines spread out less on the soft hydrogels compared to TCPS, confirming the results of many other 
groups.6, 34, 38-41 Cells were unable to spread out on 2D hydrogels that were not functionalized with protein 
(Figure S3c-d). Comparing the 2D hydrogels by qualitative visual inspection, we observed that more cells 
could adhere to the “collagen-rich” substrate over the collagen I only substrate for both MDA-MB-231 and 
Hs578T cell lines. This result is likely due to the variety of integrin-binding sites provided by the protein 
mixture. Largely in agreement with our previous work on PEG-PC gels, we saw very little evidence of 
punctate focal adhesions in any of the conditions tested, which appears to be a general feature of these 
breast cancer cell lines.34 
PEG-Maleimide hydrogels with encapsulated cells in 3D were created with liquid handling 
robotics. Cells experience a 3D microenvironment in vivo and we adapted our 3D PEG-MAL hydrogel10 
to 96-well plates via liquid handling robotics to increase the throughput of this platform for studying cells in 
3D. As in our PEG-PC system, we could control the effective Young’s modulus of the hydrogels within the 
well plates by tuning the polymer weight percent (Figure 4a). Also, there was no significant difference 
between the stiffnesses measured for hydrogels synthesized on coverslips or in multi-well plates (Figure 
S4a), and the values reported for these hydrogels is consistent with previous reports.27 This result was 
expected since this reaction does not require UV light irraditation.27  
During gelation, the 3D PEG-MAL hydrogels covalently attached to the glass bottom plates by 
reacting to the thiol group we silane-functionalized to the surface. Most of the 3D PEG-MAL hydrogels 
remained adhered to the well surface for more than 30 days (Figure 4b). This was also observed for the 
2D PEG-PC hydrogels (Figure 3b), and this stability was dependent on the polymer weight percent, likely 
due to the number of available maleimide groups to react with the silane-functionalized surface and how 
 much the different hydrogels swell within the well (Figure 4b). It was not possible to synthesize these 3D 
Figure 4. Silane functionalization allows for the synthesis of 3D PEG-MAL hydrogels in a 96-well plate 
format. a. Indentation testing of 5, 10, and 20 wt% 3D 4-arm PEG-MAL hydrogels crosslinked with linear PEG-
dithiol measured the effective Young’s modulus of hydrogels in a 96-well plate, N  11 hydrogels per condition. b. 
Long-term 3D PEG-MAL hydrogel covalent attachment to the glass bottom 96-well plates, which were treated with 
MPT, N  6 hydrogels per condition. c. LIVE (green)/DEAD (red) imaging of MDA-MB-231 and Hs578T cells one 
day post- encapsulation with manual pipetting in the 3D hydrogel with 2 mM RGD, DGEA, or GFOGER cell-
adhesion peptides and crosslinked with PEG-dithiol or PEG-dithiol plus a Pan-MMP degradable sequence 
(indicated as degradable crosslinker). d. LIVE (green)/DEAD (red) imaging of MDA-MB-231 and Hs578T cells one 
day after encapsulation with liquid handling robotics in the 3D hydrogel with 2 mM RGD cell-adhesion peptide and 
crosslinked with PEG-dithiol or PEG-dithiol plus a Pan-MMP degradable sequence. Images are representative 
from N  3 biological replicates. e. LIVE (green)/DEAD (red) imaging of MDA-MB-231 and Hs578T cells four days 
post-encapsulation at selected conditions. Scale bar = 100 m. Statistical significance where p<0.05 is denoted 
with * and ≤0.001 with ***. 
 
 PEG-MAL hydrogels in plates that were not silane treated, because the hydrogels wicked to the sides of 
the wells. When we synthesized the hydrogels on silane treated coverslips, they adhered for more than 
100 days (Figure S4b-c).  
As a proof-of-concept study, we encapsulated MDA-MB-231 or Hs578T cells in 3D PEG-MAL 
hydrogels with both manual pipetting (Figure 4c,e) and liquid handling robotics (Figure 4d-e). We chose 
three peptide sequences, RGD, GFOGER, and DGEA, that represent cell-adhesion sites in collagen I 
(GFOGER & DGEA)42-44 and fibronectin/vitronectin/osteopontin (RGD).43,45 Additionally, an enzyme-
degradable crosslinker (Pan-MMP, GPQGIWGQ) was incorporated into some of the hydrogels to allow 
the cells to degrade and move through the matrix. Cell viability was measured at one and four days post-
encapsulation via LIVE/DEAD staining (Figure 4c-e, S5). The cells encapsulated in hydrogels without cell-
adhesion peptides were still mostly viable one day post-encapsulation, but at four days post-
encapsulation the cell viability was clearly much lower as expected since these are adherent cell lines 
(Figure S5a). Cells were over 80% viable within the hydrogels one day post-encapsulation regardless of 
whether the hydrogels were made manually or via liquid handling robotics (Figure 4c-d). The cells 
encapsulated in the Pan-MMP degradable hydrogel had higher viability (>60%) at day four than the PDT 
only crosslinking condition (<60%, Figure S5b). We speculate that this increase in cell viability is due to 
the degradable sequences provided, which facilitated higher cell spreading, a possible explanation in the 
difference in viability. Overall, these results indicate that the PEG-MAL hydrogel system is adaptable to 
automated liquid handling robotics, and the incorporation of degradable sequences in the matrix improves 
cell viability.  
  
 DISCUSSION 
Many groups have developed biomaterial cell culture platforms and suggested that future 
applications could include drug screening.4-5,46-47 These materials could have significant impact on 
improving the data obtained by in vitro cell studies, if adapted to current high-throughput screening 
technologies. Towards this goal, we adapted our lab’s existing biomaterial technologies to 96-well plates 
and semi-automated liquid handling robotics. Our ability to adapt these materials from fully manual 
fabrication methods to semi-automated fabrication in 96-welll plates demonstrated that these materials 
are adaptable to liquid handling robotics. This is an important step for eventual implementation in an 
industrial setting, or even lab-scale screening studies. In our case, the liquid handling robotics is shared 
equipment, specifically configured for 250 L syringe pumps for pipetting. Although not possible for us to 
do in this study, modifying the syringe pumps can increase the pipetting capacity of the system. For this 
reason, we limited the use of the robotics for pipetting repeated volumes greater than 100 L. This fact 
meant that in our study, the semi-automated liquid handling robotics saved only a moderate amount of 
time relative to manual pipetting when making a few plates at a time. However, if more than 10 plates are 
needed for a study, the robotic workstation becomes a time-saver, and this savings scales upward with 
the number of plates. Protocols to use liquid handling robotics have been established for TCPS plates, 
but the incorporation of a variety of different types of biomaterials is a contribution we make here as a 
mechanism to enable higher-throughput screening with biomaterials in vitro. 
Since the importance of cell culture dimensionality has been increasingly evident,48 a tunable, 
reproducible, and easily fabricated high-throughput 3D in vitro cell culture platform is a valuable tool for 
drug screening.48-49 The Lutolf group has demonstrated the use of 3D hydrogels in a microarray made 
using automated liquid handling robotics to test many microenvironmental conditions on the regulation of 
mouse embryonic stem cell self-renewal.50 This study was a valuable demonstration of the utility of 
biomaterials in a high-throughput format and it was an important contribution towards using synthetic 
materials for large-scale in vitro screens. In our previous 3D PEG-MAL hydrogels drug screening study,10 
we used 10 L hydrogel volumes to avoid diffusion limitations, and in 96-well plates this volume wicked to 
the edge of the wells, which limited our study 48-well plates. Here, we overcame this challenge by 
functionalizing glass well surfaces with thiol-terminated silane to covalently attach the 3D hydrogels to the 
 surface. The stiffness of the hydrogels in the plate was tunable (Figure 4a), and these hydrogels also 
stuck reliably to the surface of the plate for over 30 days (Figure 4b), which is critical for long-term cell 
culture studies. These PEG-maleimide-based hydrogels are very compliant and are appropriate for 
mimicking soft tissues. The silane chemistry could be used to attach hydrogels up to 100 days (Figure 
S4c), indicating that this surface preparation can be done well in advance of hydrogel synthesis.  
The chemistry of PEG-MAL hydrogels allows for gelation at neutral pH,27 and the encapsulated 
cells were not exposed to UV light, as is common in other systems.9, 11 The PEG-based hydrogel system 
allows the specific incorporation of cell-binding and cell-degradable functional groups, which is not 
possible with protein-based gels such as collagen51 or Matrigel.52 Moreover, these protein based gels 
have high amounts of batch-to-batch variability,53 which makes the reproducibility of results difficult in 
large scale drug screening assays. Since our synthetic 3D model only requires two components: 1) PEG, 
which allows for tuning the hydrogel stiffness, and 2) peptides, which allow for cell attachment to the 
matrix and hydrogel degradation, it is more reproducible than protein-based hydrogels where there is 
known lot-to-lot variability. To increase the throughput of this platform, we synthesized the hydrogels with 
semi-automated liquid handling robotics. After isolating the appropriate cells and preparing the hydrogel 
precursor solutions, one plate of these hydrogels can be synthesized in less than five minutes with liquid 
handling robotics, where manual pipetting takes about 20 minutes. Further, as an extension of the study 
of ECM proteins attached to glass, we incorporated peptides representative of collagen I (GFOGER & 
DGEA) or fibronectin/vitronectin/osteopontin (RGD) binding sequences and a Pan-MMP degradable 
sequence. The MDA-MB-231 and Hs578T cells maintained over 80% viability for all conditions one day 
post-seeding (Figure 4c-d, S5b). Cell viability was also maintained with the use of liquid handling robotics 
(Figure 4d-e). Looking specifically at Hs578T cells encapsulated with RGD, there was lower survival on 
day four than on day one. This may be due to a need for additional integrin-binding sites other than RGD 
or an increase in total binding sites for long-term survival in the hydrogel. This result was important for 
scaling up our 3D PEG-MAL hydrogel system for high-throughput applications.  
For situations where full-length proteins are essential, we also demonstrated a silane-based 
approach to create multi-well plate 2D hydrogels. This also allows users to capture stiffness when 3D 
geometry is unnecessary to answer the biological question at hand. Others have developed 2D hydrogel 
 platforms,7, 20 which produce perfectly flat hydrogels, but they are complicated to fabricate7 or require a 
plate insert,20 limiting the number of plates that can be made at once. Microarrays with multiple 2D 
hydrogel stiffnesses and protein binding surfaces have been developed to demonstrate that both factors 
impact mesenchymal stem cell behavior.3 Hydrogels with incorporated nanofibers to control the spatial 
arrangement of biochemical signals have also been developed,54 but this type of system is complicated to 
fabricate. Our original 96-well plate 2D PEG-PC hydrogel system design6 was hindered for scale up 
because gelation required an oxygen-free environment. Irgacure is a photoinitiator that is commonly used 
for initiating hydrogel polymerization,35-37 and it was used for 2D PEG-PC hydrogels when they were first 
developed for coverslips.34 Irgacure is not a very efficient photoinitiator26 because it does not absorb light 
readily at 365 nm,35 but this wavelength is used in other platforms that include cell encapsulation to limit 
damage to the cells.35, 55-56 Since the pre-polymer solution resides deep within the wells of black-walled 
plates, the efficacy of Irgacure was particularly problematic, and therefore it was not possible to form 
PEG-PC hydrogels in 96-well plates. Since LAP is more efficient than Irgacure, it was possible to make 
the PEG-PC hydrogels in 96-well plates using this photoinitiator. This allows the use of liquid handling 
robotics for pipetting the pre-polymer solution without initiating polymerization of hydrogels in the pipette 
tips. 
Using LAP, we could control hydrogel stiffness within the plate across three orders of magnitude, 
enabling this material to mimic most soft and elastic tissues (Figure 3a).33-34 Also, the silane treatment 
allowed for the long-term adherence of the hydrogels to the well surface (Figure 3b). Both MDA-MB-231 
and Hs578T breast cancer cell spreading was mechanosensitive, in agreement with observations by us 
and many other groups.6,34,38-41 Specific to our study, both cell lines adhered and spread more on the 
“collagen-rich” mixture than with collagen I alone (Figure 3c), perhaps due to the additional integrin 
binding sites provided. Both MDA-MB-231 and Hs578T breast cancer cell lines express high levels of 1 
integrin,57 which pairs with multiple integrin  subunits to bind to collagen I and fibronectin, possibly 
explaining the result we observed.  
To isolate cell-ECM binding, we developed a third form of silane-treated glass-bottom 96-well 
plate. Previous work with this platform had been limited to a 24-well plate,19 where treated glass 
coverslips were prepared and inserted by hand. Unlike the 2D and 3D hydrogel platforms, the chemical 
 functionalization to the glass cannot be performed in a fully assembled glass-bottom well plate due to the 
incompatibility of polystyrene and some of the solvents. Therefore, the custom 96-well plate format was 
created by first modifying one well plate-sized piece of glass and attaching it to a commercially available 
bottomless 96-well plate with a medical-grade adhesive. The benefits of using of a 96-well plate for 
covalently attaching ECM proteins to glass include both a reduction in costly materials, such as full-length 
proteins, and a savings in time to prepare the platform, particularly since we chemically modified and 
attached a single piece of glass instead of individual glass coverslips. This approach presents a feasible 
method for scaling up to 384 or 1,536 well plates, which are also commonly used in industrial 
applications. If this approach is adopted by industry, the reproducibility of the chemistry is essential for 
quality control. We noted from XPS that the reaction stoichiometry was not 100% efficient (Figure 2a-b). 
This could be due to the starting glass not being completely pure/clean or some amount of APTES layer 
peeling typical of multilayer silane formation25 In an attempt to maximize silane monolayers vs multilayers, 
our silane deposition was done in the vapor phase, but multilayer silanes are still possible. Regardless, 
we showed that the surface concentration of protein in each well can be carefully controlled (Figure 2c-d), 
and these 2D biomaterial platforms could be used as a straightforward way to study tumor progression 
where collagen density increases and ECM composition changes.58 We observed an overall trend of 
increasing cell area in MDA-MB-231 cells with increasing collagen I surface concentration (Figure 2e), 
alongside a decrease in the circularity of the Hs578T cells (Figure 2f). These types of studies may help 
identify a certain threshold of ligand density where efficacy of a compound is greatly enhanced or 
reduced.  
The use of synthetic biomaterials allows for the capture of both biochemical and mechanical cues 
experienced by cells in vivo. These rationally designed in vitro models are beneficial because 
components of the microenvironment can be controlled individually, which is an impossible task in vivo. 
The likely application of interest for each platform will be dependent on the user’s end goal. For example, 
the ECM proteins attached to glass and 2D PEG-PC hydrogels incorporate full-length proteins, whereas 
the 3D PEG-MAL hydrogels only include peptides representative of integrin-binding sequences to specific 
proteins. Since the structure of the protein can impact integrin-binding,59-60 it is an important consideration 
in biomaterial choice. Our goal was to present mechanisms to use each of these platforms in 96-well 
 plates with semi-automated liquid handling robotics to enable high-throughput applications in the future. 
Specific features included in each, such as protein versus peptide, stiffness, and geometry will guide their 
exact applications in individual labs or companies.  
CONCLUSIONS 
We have adapted three unique, but complementary biomaterial platforms to 96-well plates and 
used semi-automated liquid handling robotics to enable high-throughput screening applications. Each 
platform was modified from existing technology to reduce material requirements and fabrication time per 
condition. Specifically, our 2D hydrogels can be synthesized with a photoinitiator in a 96-well plate in the 
presence of oxygen, our 3D hydrogels synthesis can be semi-automated to reduce the time invested per 
plate by four-fold, and our custom 96-well plate design enables screening on controlled glass substrate 
compositions. While more complex and expensive than traditional TCPS, these systems include specific 
microenvironmental features that could be key to better predict in vivo cell behavior, either for applications 
in preclinical drug screening or as better tools for hypothesis test-beds. 
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Supplemental Materials and Methods: DGEA synthesis 
Figure S1: Custom glass bottom 96-well plates can be made with commercially available materials. 
Figure S2: XPS survey traces for the chemical modification steps to prepare ECM proteins attached to 
glass. 
Figure S3: 2D PEG-PC hydrogels can also be made on coverslips and cells do not attach to hydrogels 
without protein functionalization. 
Figure S4: 3D PEG-MAL hydrogels can also be made on coverslips. 
Figure S5: Cell viability in 3D PEG-MAL hydrogels. 
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